Kyle Jenne's most recent trade in Ionis Pharmaceuticals Inc was a trade of 32,602 Common Stock done at an average price of $46.1 . Disclosure was reported to the exchange on March 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.10 per share. | 10 Mar 2026 | 32,602 | 48,991 (0%) | 0% | 46.1 | 1,502,952 | Common Stock |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 32,602 | 32,601 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Sale of securities on an exchange or to another person at price $ 75.50 per share. | 10 Mar 2026 | 21,191 | 27,800 (0%) | 0% | 75.5 | 1,599,963 | Common Stock |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Sale of securities on an exchange or to another person at price $ 76.30 per share. | 10 Mar 2026 | 16,086 | 11,714 (0%) | 0% | 76.3 | 1,227,362 | Common Stock |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2026 | 4,675 | 14,025 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.69 per share. | 10 Mar 2026 | 4,675 | 16,389 (0%) | 0% | 34.7 | 162,176 | Common Stock |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 25,800 | 44,500 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 9,675 | 37,725 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 7,013 | 29,664 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 7,013 | 18,212 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Sale of securities on an exchange or to another person at price $ 75.96 per share. | 15 Jan 2026 | 1,823 | 16,389 (0%) | 0% | 76.0 | 138,475 | Common Stock |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 19,350 | 19,350 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 12,226 | 14,215 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 12,226 | 36,677 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Sale of securities on an exchange or to another person at price $ 28.36 per share. | 15 Apr 2025 | 3,016 | 11,199 (0%) | 0% | 28.4 | 85,534 | Common Stock |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,050 | 28,050 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 18,700 | 18,700 | - | - | Performance Restricted Stock Units | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 18,700 | 18,700 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 65,203 | 65,203 | - | - | Non-Qualified Stock Option (right to buy) |